Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-27 Sale | 2026-07-29 4:05 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $20 | $20,000 | 176,526 (Direct) | View |
| 2026-06-30 Sale | 2026-07-02 4:05 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 4,654 | $20 | $93,080 | 292,618 (Direct) | View |
| 2026-06-23 Sale | 2026-06-25 5:24 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,450 | $18 | $26,100 | 168,647 (Direct) | View |
| 2026-05-28 Sale | 2026-06-01 4:05 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $16 | $10,864 | 165,443 (Direct) | View |
| 2026-05-15 Sale | 2026-05-19 4:10 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $18.76 | $56,280 | 132,247 (Direct) | View |
| 2026-05-05 Sale | 2026-05-07 4:16 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 108,234 | $20.61 | $2,230,367 | 611,427 (Direct) | View |
| 2026-04-06 Sale | 2026-04-08 4:51 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,970 | $18.01 | $71,508 | 214,152 (Direct) | View |
| 2026-04-01 Sale | 2026-04-03 3:13 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $16 | $10,864 | 151,951 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 4:07 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 25,492 | $16.15 | $411,607 | 367,130 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-27 Exercise | 2026-07-29 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $12.65 | 176,526 (Direct) | View |
| 2026-07-27 Exercise | 2026-07-29 4:05 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $0 | 176,526 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 2,875 | $12.65 | 292,618 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,779 | $8.04 | 292,618 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 4:05 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 4,654 | $0 | 292,618 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 5:24 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,450 | $8.04 | 168,647 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 5:24 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,450 | $0 | 168,647 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 5:00 pm | N/A 2026-06-16 | Cullinan Therapeutics Inc. | CGEM | Doyle Mittie Director | 21,781 | $0 | 21,781 (Direct) | View |
| 2026-06-10 Tax Withholding | 2026-06-12 4:26 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,084 | $13.1 | 51,776 (Direct) | View |
| 2026-05-28 Exercise | 2026-06-01 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $8.04 | 165,443 (Direct) | View |
| 2026-05-28 Exercise | 2026-06-01 4:05 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $0 | 165,443 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 43,500 | $0 | 47,122 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $12.65 | 132,247 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:10 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $0 | 132,247 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 78,905 | $12.65 | 611,427 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 29,329 | $8.04 | 611,427 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 108,234 | $0 | 611,427 (Direct) | View |
| 2026-04-06 Exercise | 2026-04-08 4:51 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,970 | $12.65 | 214,152 (Direct) | View |
| 2026-04-06 Exercise | 2026-04-08 4:51 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,970 | $0 | 214,152 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 3:13 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $8.04 | 151,951 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 3:13 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $0 | 151,951 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 19,500 | $12.65 | 367,130 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 5,992 | $8.04 | 367,130 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 25,492 | $0 | 367,130 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:23 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-12 4:18 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,013 | $4.1 | 3,622 (Direct) | View |
| 2025-08-07 Option Award | 2025-08-08 5:30 pm | N/A 2035-08-07 | Cullinan Therapeutics Inc. | CGEM | Doyle Mittie Director | 79,456 | $0 | 79,456 (Direct) | View |
| 2025-01-28 Option Award | 2025-01-30 5:20 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 155,000 | $0 | 155,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-16 4:23 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 234,000 | $0 | 234,000 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-01 6:27 pm | N/A 2032-03-31 | DICE Therapeutics Inc. | DICE | Doyle Mittie Director | 42,500 | $0 | 42,500 (Direct) | View |
Ownership | 2022-04-01 6:12 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Doyle Mittie Director | 0 | $0 | 0 (Direct) | View |